메뉴 건너뛰기




Volumn 23, Issue 2, 2005, Pages 87-92

High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy

Author keywords

Genetics; LOH; Prognosis; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 20944442755     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.08.015     Document Type: Article
Times cited : (4)

References (30)
  • 1
    • 0033526309 scopus 로고    scopus 로고
    • Natural history of progression after PSA elevation following radical prostatectomy
    • C.R. Pound, A.W. Partin, M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
    • (1999) JAMA , vol.281 , pp. 1591-1597
    • Pound, C.R.1    Partin, A.W.2    Eisenberger, M.A.3
  • 2
    • 0032550753 scopus 로고    scopus 로고
    • A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
    • M.W. Kattan, J.A. Eastham, A.M. Stapleton A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766 771
    • (1998) J Natl Cancer Inst , vol.90 , pp. 766-771
    • Kattan, M.W.1    Eastham, J.A.2    Stapleton, A.M.3
  • 3
    • 0030913315 scopus 로고    scopus 로고
    • Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
    • A.W. Partin, M.W. Kattan, E.N. Subong Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1997 1445 1451
    • (1997) JAMA , vol.277 , pp. 1445-1451
    • Partin, A.W.1    Kattan, M.W.2    Subong, E.N.3
  • 4
    • 0033786710 scopus 로고    scopus 로고
    • Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer
    • M.L. Blute, E.J. Bergstralh, A.W. Partin Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer J Urol 164 2000 1591 1595
    • (2000) J Urol , vol.164 , pp. 1591-1595
    • Blute, M.L.1    Bergstralh, E.J.2    Partin, A.W.3
  • 5
    • 0042674136 scopus 로고    scopus 로고
    • Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse
    • S.M. Henshall, D.E. Afar, J. Hiller Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse Cancer Res 63 2003 4196 4203
    • (2003) Cancer Res , vol.63 , pp. 4196-4203
    • Henshall, S.M.1    Afar, D.E.2    Hiller, J.3
  • 6
    • 0038079912 scopus 로고    scopus 로고
    • Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: A 5-year follow-up study
    • S. Bettuzzi, M. Scaltriti, A. Caporali Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data a 5-year follow-up study Cancer Res 63 2003 3469 3472
    • (2003) Cancer Res , vol.63 , pp. 3469-3472
    • Bettuzzi, S.1    Scaltriti, M.2    Caporali, A.3
  • 7
    • 0042191696 scopus 로고    scopus 로고
    • Allelic losses in localized prostate cancer: Association with prognostic factors
    • G. Fromont, V. Joulin, K. Chantrel-Groussard Allelic losses in localized prostate cancer association with prognostic factors J Urol 170 Pt 1 2003 1394 1397
    • (2003) J Urol , vol.170 , Issue.1 PART , pp. 1394-1397
    • Fromont, G.1    Joulin, V.2    Chantrel-Groussard, K.3
  • 8
    • 0142008439 scopus 로고    scopus 로고
    • The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer
    • M.W. Kattan, S.F. Shariat, B. Andrews The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer J Clin Oncol 21 2003 3573 3579
    • (2003) J Clin Oncol , vol.21 , pp. 3573-3579
    • Kattan, M.W.1    Shariat, S.F.2    Andrews, B.3
  • 9
    • 0028808266 scopus 로고
    • Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer
    • A. Latil, O. Cussenot, G. Fournier Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer Clin Cancer Res 1 1995 1385 1389
    • (1995) Clin Cancer Res , vol.1 , pp. 1385-1389
    • Latil, A.1    Cussenot, O.2    Fournier, G.3
  • 10
    • 0034796683 scopus 로고    scopus 로고
    • Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer
    • H. Matsuyama, Y. Pan, K. Oba Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer Clin Cancer Res 7 2001 3139 3143
    • (2001) Clin Cancer Res , vol.7 , pp. 3139-3143
    • Matsuyama, H.1    Pan, Y.2    Oba, K.3
  • 11
    • 0030995091 scopus 로고    scopus 로고
    • Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: Identification of three independent regions
    • A. Latil, O. Cussenot, G. Fournier Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma identification of three independent regions Cancer Res 57 1997 1058 1062
    • (1997) Cancer Res , vol.57 , pp. 1058-1062
    • Latil, A.1    Cussenot, O.2    Fournier, G.3
  • 12
    • 0029997010 scopus 로고    scopus 로고
    • Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
    • M.L. Cher, G.S. Bova, D.H. Moore Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping Cancer Res 56 1996 3091 3102
    • (1996) Cancer Res , vol.56 , pp. 3091-3102
    • Cher, M.L.1    Bova, G.S.2    Moore, D.H.3
  • 13
    • 0033560009 scopus 로고    scopus 로고
    • Role of radical prostatectomy in patients with prostate cancer of high Gleason score
    • M.V. Tefilli, E.L. Gheiler, R. Tiguert Role of radical prostatectomy in patients with prostate cancer of high Gleason score Prostate 39 1999 60 66
    • (1999) Prostate , vol.39 , pp. 60-66
    • Tefilli, M.V.1    Gheiler, E.L.2    Tiguert, R.3
  • 14
    • 0032699925 scopus 로고    scopus 로고
    • P53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy
    • G.B. Stackhouse, I.A. Sesterhenn, J.J. Bauer p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy J Urol 162 1999 2040 2045
    • (1999) J Urol , vol.162 , pp. 2040-2045
    • Stackhouse, G.B.1    Sesterhenn, I.A.2    Bauer, J.J.3
  • 15
    • 0029922216 scopus 로고    scopus 로고
    • Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53
    • H.J. Stricker, J.K. Jay, M.D. Linden Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53 Urology 47 1996 366 369
    • (1996) Urology , vol.47 , pp. 366-369
    • Stricker, H.J.1    Jay, J.K.2    Linden, M.D.3
  • 16
    • 0029795396 scopus 로고    scopus 로고
    • Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer
    • J.J. Bauer, I.A. Sesterhenn, F.K. Mostofi Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer J Urol 156 1996 1511 1516
    • (1996) J Urol , vol.156 , pp. 1511-1516
    • Bauer, J.J.1    Sesterhenn, I.A.2    Mostofi, F.K.3
  • 17
    • 0033762814 scopus 로고    scopus 로고
    • Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer
    • A.N. Vis, M.A. Noordzij, K. Fitoz Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer J Urol 164 2000 2156 2161
    • (2000) J Urol , vol.164 , pp. 2156-2161
    • Vis, A.N.1    Noordzij, M.A.2    Fitoz, K.3
  • 18
    • 0034049106 scopus 로고    scopus 로고
    • Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections
    • A.N. Vis, R. Kranse, A.L. Nigg Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections Am J Clin Pathol 113 2000 369 373
    • (2000) Am J Clin Pathol , vol.113 , pp. 369-373
    • Vis, A.N.1    Kranse, R.2    Nigg, A.L.3
  • 19
    • 0242608654 scopus 로고    scopus 로고
    • Use of expression analysis to predict outcome after radical prostatectomy
    • P.G. Febbo, W.R. Sellers Use of expression analysis to predict outcome after radical prostatectomy J Urol 170 Pt 2 2003 S11 S19 discussion S19-20.
    • (2003) J Urol , vol.170 , Issue.2 PART
    • Febbo, P.G.1    Sellers, W.R.2
  • 20
    • 19044391072 scopus 로고    scopus 로고
    • Gene expression correlates of clinical prostate cancer behavior
    • D. Singh, P.G. Febbo, K. Ross Gene expression correlates of clinical prostate cancer behavior Cancer Cell 1 2002 203 209
    • (2002) Cancer Cell , vol.1 , pp. 203-209
    • Singh, D.1    Febbo, P.G.2    Ross, K.3
  • 21
    • 0036074561 scopus 로고    scopus 로고
    • Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer
    • N. Tsuchiya, J.M. Slezak, M.M. Lieber Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer Genes Chromosomes Cancer 34 2002 363 371
    • (2002) Genes Chromosomes Cancer , vol.34 , pp. 363-371
    • Tsuchiya, N.1    Slezak, J.M.2    Lieber, M.M.3
  • 22
    • 0033568130 scopus 로고    scopus 로고
    • Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma
    • K. Sato, J. Qian, J.M. Slezak Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma J Natl Cancer Inst 91 1999 1574 1580
    • (1999) J Natl Cancer Inst , vol.91 , pp. 1574-1580
    • Sato, K.1    Qian, J.2    Slezak, J.M.3
  • 23
    • 0031938047 scopus 로고    scopus 로고
    • Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer
    • R. Jenkins, S. Takahashi, K. DeLacey Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer Genes Chromosomes Cancer 21 1998 131 143
    • (1998) Genes Chromosomes Cancer , vol.21 , pp. 131-143
    • Jenkins, R.1    Takahashi, S.2    Delacey, K.3
  • 24
    • 0029116273 scopus 로고
    • Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression
    • S. Takahashi, A.L. Shan, S.R. Ritland Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression Cancer Res 55 1995 4114 4119
    • (1995) Cancer Res , vol.55 , pp. 4114-4119
    • Takahashi, S.1    Shan, A.L.2    Ritland, S.R.3
  • 25
    • 0035065492 scopus 로고    scopus 로고
    • Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31
    • J.C. Zenklusen, C.J. Conti, E.D. Green Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31 Nat Genet 27 2001 392 398
    • (2001) Nat Genet , vol.27 , pp. 392-398
    • Zenklusen, J.C.1    Conti, C.J.2    Green, E.D.3
  • 26
    • 0042329653 scopus 로고    scopus 로고
    • Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion
    • A. Latil, L. Chene, P. Mangin Extensive analysis of the 13q14 region in human prostate tumors DNA analysis and quantitative expression of genes lying in the interval of deletion Prostate 57 2003 39 50
    • (2003) Prostate , vol.57 , pp. 39-50
    • Latil, A.1    Chene, L.2    Mangin, P.3
  • 27
    • 0035155439 scopus 로고    scopus 로고
    • Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer
    • J.T. Dong, J.C. Boyd, H.F. Frierson Jr Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer Prostate 49 2001 166 171
    • (2001) Prostate , vol.49 , pp. 166-171
    • Dong, J.T.1    Boyd, J.C.2    Frierson Jr., H.F.3
  • 28
    • 0345374576 scopus 로고    scopus 로고
    • Genome-wide scan of brothers: Replication and fine mapping of prostate cancer susceptibility and aggressiveness loci
    • J.S. Witte, B.K. Suarez, B. Thiel Genome-wide scan of brothers replication and fine mapping of prostate cancer susceptibility and aggressiveness loci Prostate 57 2003 298 308
    • (2003) Prostate , vol.57 , pp. 298-308
    • Witte, J.S.1    Suarez, B.K.2    Thiel, B.3
  • 29
    • 0033035090 scopus 로고    scopus 로고
    • Deletion mapping at 12p12-13 in metastatic prostate cancer
    • A.S. Kibel, D. Freije, W.B. Isaacs Deletion mapping at 12p12-13 in metastatic prostate cancer Genes Chromosomes Cancer 25 1999 270 276
    • (1999) Genes Chromosomes Cancer , vol.25 , pp. 270-276
    • Kibel, A.S.1    Freije, D.2    Isaacs, W.B.3
  • 30
    • 0033921023 scopus 로고    scopus 로고
    • Loss of heterozygosity at 12P12-13 in primary and metastatic prostate adenocarcinoma
    • A.S. Kibel, D.A. Faith, G.S. Bova Loss of heterozygosity at 12P12-13 in primary and metastatic prostate adenocarcinoma J Urol 164 2000 192 196
    • (2000) J Urol , vol.164 , pp. 192-196
    • Kibel, A.S.1    Faith, D.A.2    Bova, G.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.